Sakar Healthcare growth over the years

·UnclassifiedChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Compounded a year1 yr3 yr
Revenue+41.8%+23.6%
EBITDA+38.7%+27.6%
Net Income+74.2%+33.7%
EPS (adj.)+74.2%+33.7%
Total Assets+15.8%+12.7%
Total Equity+13.7%+23.2%
Free Cash Flow+1,385.1%—
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SAKAR₹946.50

Sakar Healthcare Limited

· Unclassified
₹ CrorePeersMACPOWERSERVOTECHKAPSTONTHEJOBETAMcap ₹2,106 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
3Y
CAGR
Revenue+41.8+23.6
EBITDA+38.7+27.6
Net Income+74.2+33.7
EPS (adj.)+74.2+33.7
Total Assets+15.8+12.7
Total Equity+13.7+23.2
Free Cash Flow+1385.1—
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.